Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent and Metastatic Endometrial Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05121363
What this trial is testing

A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial Carcinoma

Who this might be right for
Endometrial Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 113
Early research (Phase 1)Study completedNCT02922764
What this trial is testing

RGX-104 in Patients With Advanced Lung & Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Cancer RecurrentLung Cancer Recurrent+3 more
Inspirna, Inc. 146
Early research (Phase 1)WithdrawnNCT04498520
What this trial is testing

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more
Pamela Munster
Early research (Phase 1)Study completedNCT01198184
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors

Who this might be right for
Endometrial Papillary Serous CarcinomaRecurrent Endometrial CarcinomaRecurrent Renal Cell Cancer+5 more
National Cancer Institute (NCI) 18
Not applicableStudy completedNCT05364905
What this trial is testing

Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma

Who this might be right for
OncologyEndometrial CancerAdvanced Cancer+2 more
ARCAGY/ GINECO GROUP 200
Testing effectiveness (Phase 2)Ended earlyNCT01251354
What this trial is testing

Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy

Who this might be right for
Endometrial Cancer
Ipsen 6
Testing effectiveness (Phase 2)Ended earlyNCT05001282
What this trial is testing

Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Who this might be right for
Ovarian CancerOvarian NeoplasmsOvarian Carcinoma+22 more
Elucida Oncology 79
Testing effectiveness (Phase 2)Looking for participantsNCT06917092
What this trial is testing

QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableActive Not RecruitingNCT05931445
What this trial is testing

Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer

Who this might be right for
Breast CancerLung CancerColorectal Cancer+5 more
Comprehensive Support Project for Oncology Research 500
Testing effectiveness (Phase 2)Looking for participantsNCT06413992
What this trial is testing

Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer

Who this might be right for
Endometrial CarcinomaTP53 MutationRecurrent or Metastatic
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 117
Testing effectiveness (Phase 2)Study completedNCT03345485
What this trial is testing

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

Who this might be right for
Small Cell Lung CancerSoft Tissue SarcomaTriple-negative Breast Cancer+2 more
Mundipharma Research Limited 71
Testing effectiveness (Phase 2)Active Not RecruitingNCT03660826
What this trial is testing

Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

Who this might be right for
Endometrial AdenocarcinomaEndometrial Mixed Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+3 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Testing effectiveness (Phase 2)Looking for participantsNCT06532539
What this trial is testing

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Who this might be right for
Endometrial NeoplasmsNeoplasm Recurrence, LocalNeoplasm Metastasis
Shandong Cancer Hospital and Institute 30
Testing effectiveness (Phase 2)Study completedNCT00003127
What this trial is testing

S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer

Who this might be right for
Endometrial Cancer
SWOG Cancer Research Network 57
Testing effectiveness (Phase 2)Study completedNCT00053794
What this trial is testing

Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerSarcoma
NCIC Clinical Trials Group 17
Early research (Phase 1)Study completedNCT01209195
What this trial is testing

MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers

Who this might be right for
Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer,Primary Peritoneal Cancer or Endometrial CancerLocally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer
Merrimack Pharmaceuticals 41
Testing effectiveness (Phase 2)UnknownNCT05705505
What this trial is testing

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

Who this might be right for
Endometrioid Endometrial Cancer
Traws Pharma, Inc. 60
Large-scale testing (Phase 3)Ended earlyNCT00016341
What this trial is testing

Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT03394027
What this trial is testing

ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma

Who this might be right for
Triple Negative Breast CancerEndometrial CancerHormone Receptor Positive, HER2 Negative Breast Cancer
National Cancer Institute (NCI) 30
Next Page
288